< Back to companies

OncoStem develops innovative prognostic tests that assess the aggressiveness of tumours based on in-depth knowledge of tumour biology, to identify the unique characteristics of cancer recurrence risk. OncoStem’s vision is to empower doctors with evidence-based treatment plans with their smart prognostic tests. These actionable tests help physicians formulate a customized treatment plan by understanding tumour biology.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2011
Website
www.canassistbreast.com/

Categories

CancerDiagnosticsDrug Discovery/Development
Only accessible to MedStartr community members. Join now

What do you think of OncoStem?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now